]>
IRCT20130917014693N9 IRCT 2019-08-15 Shahid Beheshti University of Medical Sciences Evaluation of a new protocol for controlling blood glucose in hospitalized patients Evaluation of a new protocol for controlling blood glucose and comparing it with old strategies for controlling blood glucose in patients who hospitalized in infectious ward 2017-04-04 anticipated 108 Complete https://irct.ir/trial/40932 interventional Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. 3 Condition 1: Diabetes. Condition 2: Pneumonia. Condition 3: cellulitis. Condition 4: Diabetic foot infection. Intervention 1: Intervention group: In this group the needed daily insulin calculate. This dose includes short acting insulin (Regular, Exir Company) and long action insulin (NPH, Exir Company). The patients will receive this combined dose as twice day by subcutaneous injection. This dose will be administered every morning and every evening. This protocol will be continued in all of hospitalization duration. Intervention 2: Control group: In this group, the blood glucose level of patients will be determined before each essential meals by glucometer. Then, different doses of short acting insulin (Regular, Exir Company) will be administered by subcutaneous injection. This protocol will be continued in all of hospitalization duration. Yes - There is a plan to make this available What will be shared: Primary outcome data after making unrecognizable will be released. When: Six months after publishing the results primary outcome data will be released. To whom: Researchers after allowance of corresponding author could have the permission to have the data. Conditions: Performing any analysis will be allowed only with the permission of corresponding author. Where to obtain: Corresponding researcher How to obtain: After requesting to reach data, corresponding author will check the allowance, then the researcher will be informed about it. Comments:
public Zahra Sahraei
Niayesh Highway, Valiasr Ave, Tehran, Iran
Tehran Iran (Islamic Republic of) 1991953381 +98 21 8820 0118 zahra.sahraei@yahoo.com Shahid Beheshti University of Medical Sciences scientific Zahra Sahraei
Vali-e Asr Ave.,Niayesh junction
Tehran Iran (Islamic Republic of) 1991953381 +98 21 8887 3704 zahra.sahraei@yahoo.com Shahid Beheshti University of Medical Sciences Iran (Islamic Republic of) Patients with diabetes mellitus Age more than 18 years ago Patients under subcutaneous insulin regimen Patients who hospitalized in infectious diseases ward due to pneumonia, cellulitis, and diabetic foot infection 18 years 65 years Both Pregnant women Surgical patients Patients on intravenous insulin Patients with end stage renal disease Patients on total parental nutrition Patients who did not sign the patient informed consent form E08 B95.3 L03.03 Z86.31 Diabetes mellitus due to underlying condition Streptococcus pneumoniae as the cause of diseases classified elsewhere Cellulitis of toe Personal history of diabetic foot ulcer Treatment - Drugs Treatment - Drugs Intervention group: In this group the needed daily insulin calculate. This dose includes short acting insulin (Regular, Exir Company) and long action insulin (NPH, Exir Company). The patients will receive this combined dose as twice day by subcutaneous injection. This dose will be administered every morning and every evening. This protocol will be continued in all of hospitalization duration. Control group: In this group, the blood glucose level of patients will be determined before each essential meals by glucometer. Then, different doses of short acting insulin (Regular, Exir Company) will be administered by subcutaneous injection. This protocol will be continued in all of hospitalization duration. Blood glucose level. Timepoint: Every six hours. Method of measurement: Glucometer. Fever. Timepoint: Every six hours. Method of measurement: Mercury Therommeter. Durration of hospitalization. Timepoint: At discharged. Method of measurement: Patient record. Shahid Beheshti University of Medical Sciences Approved 2017-03-07 Research Ethics Committee of School of Pharmacy and Nursing & Midwifery- Shahid Beheshti University Arabi Ave, Daneshjoo Blvd, Velenjak, Tehran, Iran. Tehran Tehran Iran (Islamic Republic of)